News Image

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Provided By GlobeNewswire

Last update: Aug 12, 2025

Second quarter 2025 revenues were $15.0 million

Emrosi™ net sales of $2.8 million generated in first full quarter on the market

Read more at globenewswire.com

JOURNEY MEDICAL CORP

NASDAQ:DERM (8/15/2025, 8:15:37 PM)

After market: 6.3259 -0.62 (-8.98%)

6.95

-0.31 (-4.27%)


FORTRESS BIOTECH INC

NASDAQ:FBIO (8/15/2025, 8:18:30 PM)

After market: 2.17 +0.05 (+2.36%)

2.12

+0.16 (+8.16%)



Find more stocks in the Stock Screener

DERM Latest News and Analysis

Follow ChartMill for more